Geneos Wealth Management’s CMB.TECH NV CMBT Stock Holding History

Geneos Wealth Management’s Portfolio CMBT Stock Details CMBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.66K	Hold	190	–	–	﹤0.01%	2291
2026 Q1	$2.4K	Hold	190	–	–	﹤0.01%	2286
2025 Q4	$1.83K	Hold	190	–	–	﹤0.01%	2329
2025 Q3	$1.78K	Buy	+190	New	+$1.74K	﹤0.01%	2337

Other funds holding CMBT

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geneos Wealth Management's CMBT Position: Q2 2026 in Review

Geneos Wealth Management held its CMB.TECH NV (CMBT) position steady in Q2 2026 at 190 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #2291.

Geneos Wealth Management first reported a position in CMBT in Q3 2025 and has held it in 4 quarters since. 166 funds tracked by Wall St. Rank hold CMBT as of Q2 2026.

Geneos Wealth Management held 190 shares of CMB.TECH NV worth $2.66K as of Q2 2026.
Geneos Wealth Management left its CMB.TECH NV share count unchanged in Q2 2026.
CMB.TECH NV made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2291 holding.
Geneos Wealth Management first reported a position in CMB.TECH NV in Q3 2025 and has held it in 4 quarters since.
166 funds tracked by Wall St. Rank held CMB.TECH NV as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.